Sophia Apostolidou - Publications

Can ovarian cancer screening work? A secondary analysis of the UK collaborative trial of ovarian cancer screening.

Journal: British journal of cancer

Published: December 24, 2025

Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations.

Journal: Biomarker research

Published: August 08, 2025

Extracellular vesicle and particle-based blood test for ovarian cancer screening of average risk population: a promising nested case control study using preclinical samples.

Journal: Gynecologic oncology

Published: August 05, 2025

Plasma signals of lung tumor promotion for molecular cancer prevention.

Journal: Cell

Published: July 04, 2025

Estimating the Opportunity for Early Detection of Ovarian Cancer Using Individual-Patient Data from a Large Randomized Controlled Trial.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: April 01, 2025

Improving Specificity for Ovarian Cancer Screening Using a Novel Extracellular Vesicle-Based Blood Test: Performance in a Training and Verification Cohort.

Journal: The Journal of molecular diagnostics : JMD

Published: December 14, 2023

Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials.

Journal: Health technology assessment (Winchester, England)

Published: October 16, 2023

Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials.

Journal: Contemporary clinical trials

Published: October 13, 2023

Plasma cell-free DNA methylation analysis for ovarian cancer detection: Analysis of samples from a case-control study and an ovarian cancer screening trial.

Journal: International journal of cancer

Published: May 22, 2023

Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial.

Journal: The Lancet. Oncology

Published: May 16, 2023

Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer.

Journal: Proteomics. Clinical applications

Published: December 16, 2022

Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning.

Journal: Communications medicine

Published: December 02, 2021